Trade Dyadic International, Inc. - DYAI CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0262 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.4969 |
| Open | 1.4769 |
| 1-Year Change | 12.3% |
| Day's Range | 1.4369 - 1.5369 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 1.4669 | -0.0100 | -0.68% | 1.4769 | 1.5369 | 1.4369 |
| Feb 20, 2025 | 1.4969 | 0.1000 | 7.16% | 1.3969 | 1.5669 | 1.3669 |
| Feb 19, 2025 | 1.3669 | -0.1300 | -8.68% | 1.4969 | 1.5069 | 1.3669 |
| Feb 18, 2025 | 1.5169 | -0.0900 | -5.60% | 1.6069 | 1.6369 | 1.4569 |
| Feb 14, 2025 | 1.6669 | 0.0200 | 1.21% | 1.6469 | 1.6969 | 1.6169 |
| Feb 13, 2025 | 1.6369 | -0.0200 | -1.21% | 1.6569 | 1.6669 | 1.6069 |
| Feb 12, 2025 | 1.5769 | -0.0300 | -1.87% | 1.6069 | 1.6269 | 1.5269 |
| Feb 11, 2025 | 1.5969 | -0.0300 | -1.84% | 1.6269 | 1.6769 | 1.5669 |
| Feb 10, 2025 | 1.6169 | 0.0500 | 3.19% | 1.5669 | 1.6869 | 1.5669 |
| Feb 7, 2025 | 1.6069 | 0.1600 | 11.06% | 1.4469 | 1.6469 | 1.4469 |
| Feb 6, 2025 | 1.4869 | -0.0200 | -1.33% | 1.5069 | 1.5169 | 1.4569 |
| Feb 5, 2025 | 1.5069 | 0.1000 | 7.11% | 1.4069 | 1.5669 | 1.4069 |
| Feb 4, 2025 | 1.4369 | 0.0200 | 1.41% | 1.4169 | 1.4969 | 1.3669 |
| Feb 3, 2025 | 1.4169 | 0.0500 | 3.66% | 1.3669 | 1.4569 | 1.3669 |
| Jan 31, 2025 | 1.4769 | -0.0100 | -0.67% | 1.4869 | 1.5069 | 1.4169 |
| Jan 30, 2025 | 1.4669 | 0.0200 | 1.38% | 1.4469 | 1.4769 | 1.4469 |
| Jan 29, 2025 | 1.4669 | -0.0300 | -2.00% | 1.4969 | 1.4969 | 1.4369 |
| Jan 28, 2025 | 1.4869 | -0.0700 | -4.50% | 1.5569 | 1.5569 | 1.4469 |
| Jan 27, 2025 | 1.4469 | 0.0000 | 0.00% | 1.4469 | 1.4869 | 1.4069 |
| Jan 24, 2025 | 1.4569 | -0.1100 | -7.02% | 1.5669 | 1.5669 | 1.3769 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Dyadic International, Inc. Company profile
About Dyadic International, Inc.
Dyadic International, Inc. is a biotechnology platform company. The Company is focused on developing C1 platform for use in human and animal pharmaceutical applications across the world. The C1 platform technology is based on the Myceliopthora thermophila fungus, which the Company named it as C1. The C1 gene expression platform is used in the discovery, development and manufacturing of biologic medicines and vaccines. The C1 technology is a fungal expression system for gene discovery, development, and production of enzymes and other proteins. The C1 technology is commercially available solutions to uptake genes and develop industrial processes to produce volumes of enzymes and other protein products. The Company is also working on COVID-19 related vaccine and antibody opportunities, including COVID-19 vaccine candidate, DYAI-100.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Dyadic International, Inc. revenues increased 66% to $2.1M. Net loss increased 20% to $8.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Development - Balancing val increase from $2M to $5.8M (expense), General and administration increase of 61% to $3.8M (expense).
Equity composition
Common Stock $.001 Par, 12/10, 100M auth., 31,138,120 issd. insiders own 6.80%.10/29/04, acquired CCP Worldwide Inc. as a reverse acquisition.01/08, Company delisted from AMEX to OTC Pink Sheets.
| Industry: | Biotechnology & Medical Research (NEC) |
1044 North U.S. Highway One
Suite 201
JUPITER
FLORIDA 33477
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com